定期使用大麻素和炎症生物标志物:系统性审查和分层的元分析
Martino Belvederi Murri1, Riccardo Guglielmo2, Alessio Zizzi2
1Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy.
Brain, behavior, and immunity
|February 25, 2026
概括
大麻使用对炎症产生影响,在休使用者中显示出亲和抗炎作用. 这表明复杂的免疫调节影响,而不是简单的抗炎反应.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 大麻使用量的增加需要了解大麻对炎症的影响.
- 现有的关于大麻素和炎症的研究是不一致的.
- 娱乐性大麻素使用对健康人群炎症的影响尚不清楚.
研究的目的:
- 检查大麻素使用与外围炎症生物标志物之间的关联.
- 综合现有的关于大麻素免疫调节作用的证据.
- 为了澄清非医疗大麻消费的炎症影响.
主要方法:
- 系统的文献搜索到2025年10月.
- 包括比较使用者与非使用者的炎症生物标志物的研究.
- 贝叶斯的多层次元分析,以聚合效应大小,计算研究和生物标志物聚类.
主要成果:
- 观察性研究 (n=178) 显示,大麻使用与较高的促炎 (SMD=0.166) 和抗炎 (SMD=0.298) 生物标志物有关.
- 对大麻 (CBD) 的随机对照试验 (RCT) 表明,促炎性标志物 (SMD=0.15) 略有增加.
- 在前性研究中没有发现一致的效应;没有发现重大出版偏差.
结论:
- 在非医疗使用者中,大麻素的使用与同时促进和抗炎调节有关.
- 这些发现表明复杂的免疫调节作用,而不是统一的抗炎转移.
- 进一步的研究对于了解长期健康结果和指导大麻素治疗方法至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
658
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
658
Inflammatory Response
17.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.5K
The JAK-STAT Signaling Pathway
13.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.4K
Inflammatory Bowel Disease IV: Pharmacological Management
860
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
860
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
651
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
651
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
577
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
577


